{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:18:26Z","timestamp":1790093906586,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>This work introduces a hybrid computational approach in which degree-based topological descriptors are harnessed with the aid of advanced regression models and artificial neural networks (ANNs) to predict the crucial physicochemical properties of 17 drugs for the treatment of bladder cancer. Each molecule is assigned a molecular graph, from which a series of topological descriptors such as Zagreb indices, Randic index, Atom Bond Connectivity (ABC), and Symmetric Division Degree (SSD)are computed. These indices are used as input features by various regression models along with linear, cubic, and feedforward ANNs. The performance of the models is analyzed using metrics such as Mean Squared Error (MSE), Root Mean Squared Error (RMSE), Mean Absolute Error (MAE), and the coefficient of determination <jats:inline-formula>\n              <jats:tex-math>$$(R^2)$$<\/jats:tex-math>\n            <\/jats:inline-formula>. ANNs showed the best predictive performance with the <jats:inline-formula>\n              <jats:tex-math>$$R^2$$<\/jats:tex-math>\n            <\/jats:inline-formula> value achieving 0.99. Moreover, SHAP (SHapley Additive exPlanations) analysis was used to explain the contribution of each descriptor toward the models\u2019 predictions. The findings validate the promise of the combination of graph-theoretic descriptors with the tools of machine learning to achieve solid and interpretable models of molecular property prediction, which hold the potential for drug discovery and optimization in oncologic applications.<\/jats:p>","DOI":"10.1038\/s41598-025-14175-w","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:26:16Z","timestamp":1753993576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Graph theoretic and machine learning approaches in molecular property prediction of bladder cancer therapeutics"],"prefix":"10.1038","volume":"15","author":[{"given":"Huiling","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atef F.","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Farhan","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osman Abubakar","family":"Fiidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,31]]},"reference":[{"key":"14175_CR1","unstructured":"West, D. B. Introduction to Graph Theory Vol. 2 (Prentice Hall, 2001)."},{"key":"14175_CR2","unstructured":"Tutte, W. T. Graph Theory Vol. 21 (Cambridge University Press, 2001)."},{"key":"14175_CR3","doi-asserted-by":"crossref","unstructured":"Bondy, J. A. & Murty, U. S. R. Graph Theory with Applications Vol. 290 (Macmillan, 1976).","DOI":"10.1007\/978-1-349-03521-2"},{"key":"14175_CR4","unstructured":"Wilson, R. J. Introduction to Graph Theory (Pearson Education India, 1979)."},{"key":"14175_CR5","doi-asserted-by":"crossref","unstructured":"Wagner, S. & Wang, H. Introduction to Chemical Graph Theory (Chapman and Hall\/CRC, 2018).","DOI":"10.1201\/9780429450532"},{"issue":"5","key":"14175_CR6","volume":"14","author":"LS Leite","year":"2024","unstructured":"Leite, L. S., Banerjee, S., Wei, Y., Elowitt, J. & Clark, A. E. Modern chemical graph theory. Wiley Interdiscip. Rev. 14(5), e1729 (2024).","journal-title":"Wiley Interdiscip. Rev."},{"issue":"14","key":"14175_CR7","doi-asserted-by":"publisher","first-page":"8502","DOI":"10.1039\/D3TA06190F","volume":"12","author":"J Ojih","year":"2024","unstructured":"Ojih, J., Al-Fahdi, M., Yao, Y., Hu, J. & Hu, M. Graph theory and graph neural network assisted high-throughput crystal structure prediction and screening for energy conversion and storage. J. Mater. Chem. A 12(14), 8502\u20138515 (2024).","journal-title":"J. Mater. Chem. A"},{"issue":"3","key":"14175_CR8","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1039\/D4CP02764G","volume":"27","author":"S Bougueroua","year":"2025","unstructured":"Bougueroua, S. et al. Exploiting graph theory in MD simulations for extracting chemical and physical properties of materials. Phys. Chem. Chem. Phys. 27(3), 1298\u20131309 (2025).","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"4","key":"14175_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5562\/cca2294","volume":"86","author":"I Gutman","year":"2013","unstructured":"Gutman, I. Degree-based topological indices. Croatica Chem. Acta 86(4), 351\u2013361 (2013).","journal-title":"Croatica Chem. Acta"},{"issue":"13","key":"14175_CR10","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2174\/0929867013371923","volume":"8","author":"E Estrada","year":"2001","unstructured":"Estrada, E. & Uriarte, E. Recent advances on the role of topological indices in drug discovery research. Curr. Med. Chem. 8(13), 1573\u20131588 (2001).","journal-title":"Curr. Med. Chem."},{"key":"14175_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109731","volume":"187","author":"L Huang","year":"2025","unstructured":"Huang, L., Alhulwah, K. H., Hanif, M. F., Siddiqui, M. K. & Ikram, A. S. On QSPR analysis of glaucoma drugs using machine learning with XGBoost and regression models. Comput. Biol. Med. 187, 109731 (2025).","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"14175_CR12","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1038\/s41598-025-88419-0","volume":"15","author":"H Qin","year":"2025","unstructured":"Qin, H. et al. On QSPR analysis of pulmonary cancer drugs using python-driven topological modeling. Sci. Rep. 15(1), 3965 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"14175_CR13","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41598-025-85352-0","volume":"15","author":"H Qin","year":"2025","unstructured":"Qin, H. et al. A python approach for prediction of physicochemical properties of anti-arrhythmia drugs using topological descriptors. Sci. Rep. 15(1), 1742 (2025).","journal-title":"Sci. Rep."},{"issue":"7","key":"14175_CR14","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.1080\/10406638.2023.2257848","volume":"44","author":"J Wei","year":"2024","unstructured":"Wei, J., Hanif, M. F., Mahmood, H., Siddiqui, M. K. & Hussain, M. QSPR analysis of diverse drugs using linear regression for predicting physical properties. Polycycl. Arom. Compd. 44(7), 4850\u20134870 (2024).","journal-title":"Polycycl. Arom. Compd."},{"issue":"26356","key":"14175_CR15","first-page":"1","volume":"15","author":"WE Ahmed","year":"2025","unstructured":"Ahmed, W. E., Hanif, M. F., Siddiqui, M. K. & Gegbe, B. Advanced QSPR modeling of profens using machine learning and molecular descriptors for NSAID analysis. Sci. Rep. 15(26356), 1\u201319 (2025).","journal-title":"Sci. Rep."},{"issue":"3","key":"14175_CR16","first-page":"52","volume":"15","author":"KJ Gowtham","year":"2022","unstructured":"Gowtham, K. J. A study of cellular neural networks with new vertex-edge topological indices. Int. J. Open Probl. Comput. Sci. Math. 15(3), 52\u201360 (2022).","journal-title":"Int. J. Open Probl. Comput. Sci. Math."},{"key":"14175_CR17","unstructured":"Jayanna, G. K. A study of hyaluronic acid-anticancer drug conjugates via new ve-degree topological indices (2022)."},{"key":"14175_CR18","doi-asserted-by":"crossref","unstructured":"Jayanna, G. K., Swamy, N. N., Sooryanarayana, B., & Cangul, I. N. Some properties of the novel topological graph index Atom-Bond Sum-Connectivity index (2024).","DOI":"10.21203\/rs.3.rs-4125630\/v1"},{"issue":"02","key":"14175_CR19","doi-asserted-by":"publisher","first-page":"2250077","DOI":"10.1142\/S179383092250077X","volume":"15","author":"A Alsinai","year":"2023","unstructured":"Alsinai, A., Saleh, A., Ahmed, H., Mishra, L. N. & Soner, N. D. On fourth leap Zagreb index of graphs. Discret. Math. Algorithms Appl. 15(02), 2250077 (2023).","journal-title":"Discret. Math. Algorithms Appl."},{"issue":"1","key":"14175_CR20","first-page":"5683644","volume":"2022","author":"K Julietraja","year":"2022","unstructured":"Julietraja, K., Alsinai, A. & Alameri, A. Theoretical analysis of superphenalene using different kinds of VDB indices. J. Chem. 2022(1), 5683644 (2022).","journal-title":"J. Chem."},{"issue":"6","key":"14175_CR21","doi-asserted-by":"publisher","first-page":"7214","DOI":"10.33263\/BRIAC126.72147225","volume":"12","author":"A Alsinai","year":"2021","unstructured":"Alsinai, A., Ahmed, H., Alwardi, A. & Soner, N. D. HDR degree bassed indices and Mhr-polynomial for the treatment of COVID-19. Biointerface Res. Appl. Chem. 12(6), 7214\u20137225 (2021).","journal-title":"Biointerface Res. Appl. Chem."},{"issue":"9","key":"14175_CR22","first-page":"614","volume":"3","author":"S Javaraju","year":"2021","unstructured":"Javaraju, S., Ahmed, H., Alsinai, A. & Soner, N. D. Domination topological properties of carbidopa-levodopa used for treatment Parkinson s disease by using fp-polynomial. Euras. Chem. Commun 3(9), 614\u2013621 (2021).","journal-title":"Euras. Chem. Commun"},{"issue":"2","key":"14175_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/qua.27346","volume":"124","author":"I Gutman","year":"2024","unstructured":"Gutman, I., Furtula, B. & Oz, M. S. Geometric approach to vertex-degree-based topological indices-Elliptic Sombor index, theory and application. Int. J. Quantum Chem. 124(2), e27346 (2024).","journal-title":"Int. J. Quantum Chem."},{"issue":"1","key":"14175_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/qua.27234","volume":"124","author":"M Hasani","year":"2024","unstructured":"Hasani, M. & Ghods, M. Topological indices and QSPR analysis of some chemical structures applied for the treatment of heart patients. Int. J. Quantum Chem. 124(1), e27234 (2024).","journal-title":"Int. J. Quantum Chem."},{"key":"14175_CR25","unstructured":"Furtula, B., & Oz, M. S. Complementary topological indices. Match Communications in Mathematical and in Computer Chemistry (2025)."},{"issue":"3","key":"14175_CR26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s11227-025-06967-8","volume":"81","author":"M Hasani","year":"2025","unstructured":"Hasani, M., Ghods, M., Mondal, S., Siddiqui, M. K. & Cheema, I. Z. Modeling QSPR for pyelonephritis drugs: A topological indices approach using MATLAB. J. Supercomput. 81(3), 479 (2025).","journal-title":"J. Supercomput."},{"issue":"11","key":"14175_CR27","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1200\/JCO-24-02266","volume":"43","author":"EK Mai","year":"2025","unstructured":"Mai, E. K. et al. Isatuximab, lenalidomide, bortezomib, and dexamethasone induction therapy for transplant-eligible newly diagnosed multiple myeloma: Final part 1 analysis of the GMMG-HD7 trial. J. Clin. Oncol. 43(11), 1279\u20131288 (2025).","journal-title":"J. Clin. Oncol."},{"key":"14175_CR28","doi-asserted-by":"publisher","first-page":"18394","DOI":"10.1021\/jacs.4c18394","volume":"147","author":"A Matsumoto","year":"2025","unstructured":"Matsumoto, A. et al. How temperature change affects the lattice parameters, molecular conformation, and reaction cavity in enantiomeric and racemic crystals of thalidomide. J. Am. Chem. Soc. 147, 18394 (2025).","journal-title":"J. Am. Chem. Soc."},{"key":"14175_CR29","first-page":"1","volume":"2024","author":"MA Bilen","year":"2025","unstructured":"Bilen, M. A. et al. Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial. Nat. Cancer 2024, 1\u201313 (2025).","journal-title":"Nat. Cancer"},{"key":"14175_CR30","volume":"1880","author":"W Zhang","year":"2025","unstructured":"Zhang, W., Hong, X., Xiao, Y., Wang, H. & Zeng, X. Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma. Biochim. Biophys. Acta (BBA) 1880, 189310 (2025).","journal-title":"Biochim. Biophys. Acta (BBA)"},{"issue":"2","key":"14175_CR31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/bcp.16196","volume":"91","author":"EL Giraud","year":"2025","unstructured":"Giraud, E. L. et al. Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer. Br. J. Clin. Pharmacol. 91(2), 297\u2013305 (2025).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"14175_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-025-58436-8","volume":"16","author":"R Wray","year":"2025","unstructured":"Wray, R. et al. Angiogenic and immune predictors of neoadjuvant axitinib response in renal cell carcinoma with venous tumour thrombus. Nat. Commun. 16(1), 1\u201314 (2025).","journal-title":"Nat. Commun."},{"key":"14175_CR33","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/S0140-6736(25)00403-9","volume":"405","author":"T Yau","year":"2025","unstructured":"Yau, T. et al. Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial. The Lancet 405, 1851\u20131864 (2025).","journal-title":"The Lancet"},{"issue":"1","key":"14175_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/1940-6207.CAPR-24-0194","volume":"18","author":"TM Downs","year":"2025","unstructured":"Downs, T. M. et al. Phase II clinical chemoprevention trial of weekly erlotinib before bladder cancer surgery. Cancer Prev. Res. 18(1), 31\u201339 (2025).","journal-title":"Cancer Prev. Res."},{"key":"14175_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117773","volume":"182","author":"D Beyoglu","year":"2025","unstructured":"Beyoglu, D., Hamberg, P., IJzerman, N. S., Mathijssen, R. H. & Idle, J. R. New metabolic insights into the mechanism of ifosfamide encephalopathy. Biomed. Pharmacother. 182, 117773 (2025).","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"14175_CR36","doi-asserted-by":"publisher","first-page":"14230","DOI":"10.1038\/s41598-025-98413-1","volume":"15","author":"M Delessard","year":"2025","unstructured":"Delessard, M. et al. In vivo and in vitro spermatogenesis in prepubertal mouse testes exposed to low gonadotoxic doses of cytarabine or Daunorubicin. Sci. Rep. 15(1), 14230 (2025).","journal-title":"Sci. Rep."},{"key":"14175_CR37","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.2147\/IJN.S487344","volume":"20","author":"Y Yang","year":"2025","unstructured":"Yang, Y. et al. Combined albumin polyester nanocarriers with docetaxel for effective against lung cancer in mice model. Int. J. Nanomed. 20, 2103\u20132118 (2025).","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"14175_CR38","first-page":"1","volume":"42","author":"AG Alkhathami","year":"2025","unstructured":"Alkhathami, A. G. et al. LncRNAs in modulating cancer cell resistance to paclitaxel (PTX) therapy. Med. Oncol. 42(1), 1\u201317 (2025).","journal-title":"Med. Oncol."},{"issue":"3","key":"14175_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/1873-3468.15016","volume":"599","author":"M Sarma","year":"2025","unstructured":"Sarma, M., Bora, K., Ranjan, P. & Dubey, V. K. Identification of novel anti-leishmanials targeting glutathione synthetase of the parasite: A drug repurposing approach. FEBS Lett. 599(3), 367\u2013380 (2025).","journal-title":"FEBS Lett."},{"key":"14175_CR40","doi-asserted-by":"publisher","DOI":"10.1177\/11206721251327650","author":"AK Singh","year":"2025","unstructured":"Singh, A. K. et al. Comparing the outcome of delayed postoperative versus intraoperative mitomycin C use in trabeculectomy: A randomized control trial. Eur. J. Ophthalmol. https:\/\/doi.org\/10.1177\/11206721251327650 (2025).","journal-title":"Eur. J. Ophthalmol."},{"key":"14175_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115937","volume":"240","author":"Y Lou","year":"2024","unstructured":"Lou, Y. et al. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS\/MS and its application in the clinical determination in patients with tumors associated with overactive bladder. J. Pharm. Biomed. Anal. 240, 115937 (2024).","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"14175_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s40265-019-01142-9","volume":"79","author":"A Markham","year":"2019","unstructured":"Markham, A. Erdafitinib: First global approval. Drugs 79(9), 1017\u20131021 (2019).","journal-title":"Drugs"},{"issue":"2","key":"14175_CR43","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1021\/mp300370t","volume":"10","author":"E Moysan","year":"2013","unstructured":"Moysan, E., Bastiat, G. & Benoit, J. P. Gemcitabine versus modified gemcitabine: A review of several promising chemical modifications. Mol. Pharm. 10(2), 430\u2013444 (2013).","journal-title":"Mol. Pharm."},{"issue":"1","key":"14175_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000055290","volume":"60","author":"V Heinemann","year":"2000","unstructured":"Heinemann, V. Gemcitabine: Progress in the treatment of pancreatic cancer. Oncology 60(1), 8\u201318 (2000).","journal-title":"Oncology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14175-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T09:58:42Z","timestamp":1757325522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14175-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14175"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14175-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,31]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28025"}}